そう痒症治療薬の世界市場レポート 2025年

そう痒症治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.3％で220億2,000万米ドルに成長します。予測期間の成長は、継続的な研究とイノベーション、新興市場の成長、ヘルスケア支出の増加、個別化医療の動向、イノベーションに対する規制当局の支援に起因すると考えられます。予測期間の世界の動向には、遠隔医療とデジタルヘルスの統合、技術の進歩、遠隔医療とデジタルヘルスソリューション、世界の規制状況、生物製剤と免疫調節剤、患者中心のアプローチなどが含まれます。

そう痒症治療薬の成長は、皮膚疾患の増加によって大きく促進されています。にきび、湿疹、皮膚がん、乾癬、白斑などの皮膚疾患（総称して皮膚疾患と呼ばれる）は増加傾向にあります。ほとんどの場合、そう痒症が主な症状であるため、そう痒症治療薬は様々な皮膚疾患の治療において重要な役割を果たしています。例えば、2022年4月に米国皮膚科学会が報告したメラノーマでは、2022年に7,650人が死亡すると予想されています。さらに、米国がん協会は、2023年に米国で新たに97,610例の黒色腫が診断されると予測しています。このような皮膚疾患の増加は、そう痒症治療薬市場の成長の原動力となっています。

慢性腎臓病（CKD）の有病率の上昇は、今後数年間のそう痒症治療薬市場の成長を促進すると予測されています。CKDは、腎機能が徐々に低下することを特徴とする長期的な病態であり、5段階の重症度に分類されます。一般にかゆみと呼ばれるそう痒症は、CKDに伴う一般的な症状です。CKDにおけるそう痒症の正確な原因は完全には解明されていないが、さまざまな要因が関与している可能性があります。例えば、2023年6月、腎臓病の研究とアドボカシーに焦点を当てた慈善団体であるKidney Research UKは、英国では約719万人が慢性腎臓病とともに生活しており、人口の10％以上を占めていると報告しました。この数は2033年までに761万人に増加すると予測されています。その結果、慢性腎臓病の罹患率の増加がそう痒症治療薬市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界そう痒症治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界のそう痒症治療薬市場：成長率分析
• 世界のそう痒症治療薬市場の実績：規模と成長, 2019-2024
• 世界のそう痒症治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界そう痒症治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のそう痒症治療薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• 抗ヒスタミン薬
• 局所麻酔薬
• 抗刺激剤
• 免疫抑制剤
• カルシニューリン阻害剤
• その他のタイプ
• 世界のそう痒症治療薬市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アトピー性皮膚炎または湿疹
• アレルギー性接触皮膚炎
• 蕁麻疹
• 皮膚T細胞
• その他の病気の種類
• 世界のそう痒症治療薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外用
• オーラル
• 注射
• 世界のそう痒症治療薬市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他の用途
• 世界のそう痒症治療薬市場、コルチコステロイドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所コルチコステロイド
• 全身性コルチコステロイド
• 世界のそう痒症治療薬市場抗ヒスタミン薬の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 第一世代抗ヒスタミン薬
• 第二世代抗ヒスタミン薬
• 世界のそう痒症治療薬市場局所麻酔薬の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所麻酔薬
• 注射用局所麻酔薬
• 世界のそう痒症治療薬市場、タイプ別抗刺激剤のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所麻酔薬
• 注射用局所麻酔薬
• 世界のそう痒症治療薬市場、免疫抑制剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全身免疫抑制剤
• 局所免疫抑制剤
• 世界のそう痒症治療薬市場カルシニューリン阻害剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• タクロリムス
• ピメクロリムス
• 世界のそう痒症治療薬市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗うつ薬
• 光線療法による治療
• 抗うつ薬

第7章 地域別・国別分析

• 世界のそう痒症治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のそう痒症治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• そう痒症治療薬市場：競合情勢
• そう痒症治療薬市場：企業プロファイル
  • Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Cipla Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Galderma Laboratories LP Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Abbott Laboratories
• Almirall SA
• Eisai Co. Ltd.
• Glenmark Pharmaceuticals Ltd.
• Ipca Laboratories Ltd.
• Lupin Chemicals Ltd.
• Cara Therapeutics Inc.
• EPI Health LLC
• AbbVie Inc.
• Albireo Pharma Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• そう痒症治療薬市場2029：新たな機会を提供する国
• そう痒症治療薬市場2029：新たな機会を提供するセグメント
• そう痒症治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pruritus therapeutic refers to the treatment of pruritus, an uncomfortable sensation that prompts a person to scratch. Pruritus can be caused by various factors, including contact with allergens, dry skin, pregnancy, and reactions to medications.

The main types of pruritus therapeutic treatments include corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressants, calcineurin inhibitors, and others. Corticosteroids are a type of anti-inflammatory medication that closely resembles the hormone cortisol naturally produced by the adrenal glands. Pruritus can manifest in different diseases such as atopic dermatitis or eczema, allergic contact dermatitis, urticaria, cutaneous T-cell lymphoma, and others. Treatment methods include external use through application, oral administration, and injection. These therapies are commonly employed by hospitals, clinics, and other medical facilities.

The pruritus therapeutic market research report is one of a series of new reports from The Business Research Company that provides pruritus therapeutic market statistics, including pruritus therapeutic industry global market size, regional shares, competitors with a pruritus therapeutic market share, detailed pruritus therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the pruritus therapeutic industry. This pruritus therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pruritus therapeutic market size has grown strongly in recent years. It will grow from $14.29 billion in 2024 to $15.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing prevalence of pruritus, advancements in research and development, growing aging population, expansion of healthcare infrastructure, increasing awareness among patients, collaborations and partnerships.

The pruritus therapeutic market size is expected to see strong growth in the next few years. It will grow to $22.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to continued research and innovation, emerging markets growth, rising healthcare expenditure, personalized medicine trend, regulatory support for innovation. Major trends in the forecast period include telemedicine and digital health integration, technological advancements, telehealth and digital health solutions, global regulatory landscape, biologics and immunomodulators, patient-centric approaches.

The growth of pruritus therapeutics is significantly fueled by the increasing incidences of skin disorders. Dermatologic conditions, such as acne, eczema, skin cancer, psoriasis, and vitiligo, collectively referred to as skin disorders, are on the rise. Pruritus therapeutics play a crucial role in treating various skin diseases, as pruritus is a predominant symptom in most cases. For instance, melanoma, as reported by the American Academy of Dermatology Association in April 2022, is expected to result in 7,650 deaths in 2022. Moreover, the American Cancer Society projects 97,610 new melanoma cases to be diagnosed in the United States in 2023. This increase in skin disorders underscores the driving force behind the growth of the pruritus therapeutic market.

The rising prevalence of chronic kidney disease (CKD) is anticipated to drive growth in the pruritus therapeutic market in the coming years. CKD is a long-term condition characterized by a gradual decline in kidney function and is categorized into five severity levels. Pruritus, commonly referred to as itching, is a common symptom associated with CKD. While the exact causes of pruritus in CKD are not fully understood, various factors may contribute to it. For example, in June 2023, Kidney Research UK, a charitable organization focused on research and advocacy for kidney diseases, reported that approximately 7.19 million people in the UK were living with chronic kidney disease, accounting for over 10% of the population. This number is projected to rise to 7.61 million by 2033. Consequently, the increasing incidence of chronic kidney disease is fueling the growth of the pruritus therapeutic market.

Product innovation emerges as a prominent trend in the pruritus therapeutic market, with major companies focusing on the development of innovative medications and treatments for pruritus and related conditions. An example is Maruho Co., Ltd., a Japan-based pharmaceutical company, which introduced the anti-IL-31 receptor, a humanized monoclonal antibody named Mitchga Subcutaneous Injection. Launched in August 2022, it serves as a treatment for itching associated with atopic dermatitis, inhibiting IL-31 signaling and addressing pruritus and skin inflammation.

Major companies in the pruritus therapeutic market are adopting a strategic partnership approach to address moderate-to-severe atopic dermatitis. This collaborative strategy involves leveraging each other's strengths and resources for mutual benefits. Amgen Inc., a US-based biopharmaceutical company, partnered with Kyowa Kirin to investigate rocatinlimab, a potential anti-OX40 monoclonal antibody for moderate to severe atopic dermatitis. The Phase 3 trial, known as ROCKET, is a global initiative aimed at studying the safety and effectiveness of rocatinlimab. This strategic partnership underscores the collaborative efforts in advancing therapeutic solutions.

In March 2023, Ipsen, a France-based biopharmaceutical company, acquired Albireo Pharma, Inc., a US-based biopharmaceutical company. This strategic acquisition adds promising therapies for uncommon cholestatic liver disorders, novel pipeline prospects, and technical and financial strength to Ipsen's portfolio. Albireo Pharma, Inc. specializes in developing and commercializing novel bile acid modulators for the treatment of orphan pediatric liver diseases, gastrointestinal disorders, and pruritus-related conditions in drug development.

Major companies operating in the pruritus therapeutic market include Astellas Pharma Inc., Bristol-Myers Squibb Company, Cipla Inc., Eli Lilly and Company, Galderma Laboratories LP, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Abbott Laboratories, Almirall SA, Eisai Co. Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Chemicals Ltd., Cara Therapeutics Inc., EPI Health LLC, AbbVie Inc., Albireo Pharma Inc., Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Huapont Life Sciences Co. Ltd., LEO Pharma AS, MC2 Therapeutics Ltd., Novan Inc., Trevi Therapeutics Inc., UCB SA, Viatris Inc., Teva Pharmaceutical Industries Ltd.

North America was the largest region in the pruritus therapeutic market in 2024. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pruritus therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pruritus therapeutic market includes revenues earned by entities by treating pruritus conditions with medicines such as aloe vera, menthol and petroleum jelly. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pruritus Therapeutic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pruritus therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pruritus therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pruritus therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Corticosteroids; Antihistamines; Local Anesthetics; Counterirritants; Immunosuppressant; Calcineurin Inhibitors; Others Types
• 2) By Disease Type: Atopic Dermatitis Or Eczema; Allergic Contact Dermatitis; Urticaria; Cutaneous T-Cell; Other Disease Types
• 3) By Application: External Use; Oral; Injection
• 4) By End Use: Hospitals; Clinics; Other Uses
• Subsegments:
• 1) By Corticosteroids: Topical Corticosteroids; Systemic Corticosteroids
• 2) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines
• 3) By Local Anesthetics: Topical Local Anesthetics; Injectable Local Anesthetics
• 4) By Counterirritants: Menthol-Based Products; Camphor-Based Products
• 5) By Immunosuppressants: Systemic Immunosuppressants; Topical Immunosuppressants
• 6) By Calcineurin Inhibitors: Tacrolimus; Pimecrolimus
• 7) By Other Types: Antidepressants; Phototherapy Treatments; Herbal Remedies
• Companies Mentioned: Astellas Pharma Inc.; Bristol-Myers Squibb Company; Cipla Inc.; Eli Lilly and Company; Galderma Laboratories LP
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pruritus Therapeutic Market Characteristics

3. Pruritus Therapeutic Market Trends And Strategies

4. Pruritus Therapeutic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pruritus Therapeutic Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pruritus Therapeutic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pruritus Therapeutic Market Growth Rate Analysis
• 5.4. Global Pruritus Therapeutic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pruritus Therapeutic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pruritus Therapeutic Total Addressable Market (TAM)

6. Pruritus Therapeutic Market Segmentation

• 6.1. Global Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Antihistamines
• Local Anesthetics
• Counterirritants
• Immunosuppressant
• Calcineurin Inhibitors
• Others Types
• 6.2. Global Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Atopic Dermatitis Or Eczema
• Allergic Contact Dermatitis
• Urticaria
• Cutaneous T-Cell
• Other Disease Types
• 6.3. Global Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• External Use
• Oral
• Injection
• 6.4. Global Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other Uses
• 6.5. Global Pruritus Therapeutic Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Corticosteroids
• Systemic Corticosteroids
• 6.6. Global Pruritus Therapeutic Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-Generation Antihistamines
• Second-Generation Antihistamines
• 6.7. Global Pruritus Therapeutic Market, Sub-Segmentation Of Local Anesthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Local Anesthetics
• Injectable Local Anesthetics
• 6.8. Global Pruritus Therapeutic Market, Sub-Segmentation Of Counterirritants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Local Anesthetics
• Injectable Local Anesthetics
• 6.9. Global Pruritus Therapeutic Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systemic Immunosuppressants
• Topical Immunosuppressants
• 6.10. Global Pruritus Therapeutic Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tacrolimus
• Pimecrolimus
• 6.11. Global Pruritus Therapeutic Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antidepressants
• Phototherapy Treatments
• Antidepressants

7. Pruritus Therapeutic Market Regional And Country Analysis

• 7.1. Global Pruritus Therapeutic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pruritus Therapeutic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pruritus Therapeutic Market

• 8.1. Asia-Pacific Pruritus Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pruritus Therapeutic Market

• 9.1. China Pruritus Therapeutic Market Overview
• 9.2. China Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pruritus Therapeutic Market

• 10.1. India Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pruritus Therapeutic Market

• 11.1. Japan Pruritus Therapeutic Market Overview
• 11.2. Japan Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pruritus Therapeutic Market

• 12.1. Australia Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pruritus Therapeutic Market

• 13.1. Indonesia Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pruritus Therapeutic Market

• 14.1. South Korea Pruritus Therapeutic Market Overview
• 14.2. South Korea Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pruritus Therapeutic Market

• 15.1. Western Europe Pruritus Therapeutic Market Overview
• 15.2. Western Europe Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pruritus Therapeutic Market

• 16.1. UK Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pruritus Therapeutic Market

• 17.1. Germany Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pruritus Therapeutic Market

• 18.1. France Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pruritus Therapeutic Market

• 19.1. Italy Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pruritus Therapeutic Market

• 20.1. Spain Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pruritus Therapeutic Market

• 21.1. Eastern Europe Pruritus Therapeutic Market Overview
• 21.2. Eastern Europe Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pruritus Therapeutic Market

• 22.1. Russia Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pruritus Therapeutic Market

• 23.1. North America Pruritus Therapeutic Market Overview
• 23.2. North America Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pruritus Therapeutic Market

• 24.1. USA Pruritus Therapeutic Market Overview
• 24.2. USA Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pruritus Therapeutic Market

• 25.1. Canada Pruritus Therapeutic Market Overview
• 25.2. Canada Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pruritus Therapeutic Market

• 26.1. South America Pruritus Therapeutic Market Overview
• 26.2. South America Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pruritus Therapeutic Market

• 27.1. Brazil Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pruritus Therapeutic Market

• 28.1. Middle East Pruritus Therapeutic Market Overview
• 28.2. Middle East Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pruritus Therapeutic Market

• 29.1. Africa Pruritus Therapeutic Market Overview
• 29.2. Africa Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pruritus Therapeutic Market Competitive Landscape And Company Profiles

• 30.1. Pruritus Therapeutic Market Competitive Landscape
• 30.2. Pruritus Therapeutic Market Company Profiles
  • 30.2.1. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Cipla Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Galderma Laboratories LP Overview, Products and Services, Strategy and Financial Analysis

31. Pruritus Therapeutic Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc
• 31.2. Merck & Co. Inc.
• 31.3. Novartis AG
• 31.4. Pfizer Inc.
• 31.5. Sanofi SA
• 31.6. Abbott Laboratories
• 31.7. Almirall SA
• 31.8. Eisai Co. Ltd.
• 31.9. Glenmark Pharmaceuticals Ltd.
• 31.10. Ipca Laboratories Ltd.
• 31.11. Lupin Chemicals Ltd.
• 31.12. Cara Therapeutics Inc.
• 31.13. EPI Health LLC
• 31.14. AbbVie Inc.
• 31.15. Albireo Pharma Inc.

32. Global Pruritus Therapeutic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pruritus Therapeutic Market

34. Recent Developments In The Pruritus Therapeutic Market

35. Pruritus Therapeutic Market High Potential Countries, Segments and Strategies

• 35.1 Pruritus Therapeutic Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pruritus Therapeutic Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pruritus Therapeutic Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer